Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy.

Zhang J, Sun S, Chen H, Feng Y, Li Y, Dong Z

Open source

DOI
10.3389/fphar.2023.1197144
Published
2023
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2023.1197144,
  title = {Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy.},
  author = {Zhang J and Sun S and Chen H and Feng Y and Li Y and Dong Z},
  year = {2023},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2023.1197144},
  url = {https://doi.org/10.3389/fphar.2023.1197144}
}

RIS

TY  - JOUR
TI  - Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy.
AU  - Zhang J
AU  - Sun S
AU  - Chen H
AU  - Feng Y
AU  - Li Y
AU  - Dong Z
PY  - 2023
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2023.1197144
UR  - https://doi.org/10.3389/fphar.2023.1197144
ER  - 

APA

J, Z., S, S., H, C., Y, F., Y, L., & Z, D. (2023). Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2023.1197144

Source records